Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation

Europace

Volumn 8, Issue 6, 2006, Pages 408-412

  Strandberg, Marjatta ^a   Raatikainen, M J Pekka ^b   Niemelä, Matti ^b   Luotolahti, Matti ^a   Hartiala, Jaakko ^a   Airaksinen, K E Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atrial fibrillation; Cardioversion; Stroke; Thrombus; Transoesophageal echocardiography

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DALTEPARIN; DIGOXIN; ENOXAPARIN; FLECAINIDE; LOW MOLECULAR WEIGHT HEPARIN; PROPAFENONE; SOTALOL; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CARDIOVERSION; CLINICAL PRACTICE; CLINICAL PROTOCOL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SINUS NODE; SINUS RHYTHM; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33745210542     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul034     Document Type: Article

References (31)

1. Fuster V, Rydén LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001;22:1852-923.
2. Klein AL, Grimm RA, Murray RD et al. for the Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20.
3. Elhendy A, Gentile F, Khandheria BK et al. Thromboembolic complications after electrical cardioversion in patients with atrial flutter. Am J Med 2001;111:433-8.
4. Gentile F, Elhendy A, Khandheria BK et al. Safety of electrical cardioversion in patients with atrial fibrillation. Mayo Clin Proc 2002;77:897-904.
5. Lehto M, Kala R. Persistent atrial fibrillation: A population based study of patients with their first cardioversion. Int J Cardiol 2003;92;145-50.
6. Bartel T, Erbel R. for the Acute Trial Investigators. Transoesophageal echocardiography for immediate and safe cardioversion in patients with atrial fibrillation. Eur Heart J 2001;22:2041-4.
7. Klein AL, Murray RD, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 2001;37:691-704.
8. Weigner MJ, Thomas LR, Patel U et al. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: Short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med 2001;110:694-702.
9. Asher CR, Klein AL. Transesophageal echocardiography in patients with atrial fibrillation. Pacing Clin Electrophysiol 2003;26:1597-603.
10. Chan KL, Cohen GI, Sochowski RA, Baird MG. Complications of transesophageal echocardiography in ambulatory adult patients: Analysis of 1500 consecutive examinations. J Am Soc Echocardiogr 1991;4:577-82.
11. Manning WJ, Weintraub RM, Waksmonski CA et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995;123:817-22.
12. Koca V, Bozat T, Akkaya V et al. Left atrial thrombus detection with multiplane transesophageal echocardiography: An echocardiographic study with surgical verification. J Heart Valve Dis 1999;8:63-6.
13. Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas PS. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial trombi. N Engl J Med 1993;328:750-55.
14. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study. J Am Coll Cardiol 1995;25:1354-61.
15. Corrado G, Santarone M, Beretta S et al. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: Single centre 8.5-year experience. Europace 2000;2:119-26.
16. Roijer A, Eskilsson J, Olsson B. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J 2000;21:837-47.
17. Mitusch R, Garbe M, Schmücker G, Schwabe K, Stierke U, Sheikhzadeh A. Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. Am J Cardiol 1995;75:944-7.
18. Palinkas A, Antonielli E, Picano E et al. Clinical value of left atrial appendage flow velocity for predicting of cardioversion success in patients with nonvalvular atrial fibrillation. Eur Heart J 2001;22:2201-8.
19. Verhorst PM, Kamp O, Welling RC, Van Eenige MJ, Visser CA. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation. Am J Cardiol 1997;79:1355-9.
20. Omran H, Jung W, Schimpf R et al. Echocardiographic parameters for predicting maintenance of sinus rhythm after internal atrial defibrillation. Am J Cardiol 1998;81:1446-9.
21. Antonielli E, Pizzuti A, Palinkas A et al. Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2002;39:1443-9.
22. Ökcün B, Yigit Z, Kücükoglu S et al. Predictors for maintenance of sinus rhythm after cardioversion in patients with nonvalvular atrial fibrillation. Echocardiography 2002;19:351-7.
23. Perez Y, Duval AM, Carville C et al. Is left atrial appendage flow a predictor for outcome of cardioversion of nonvalvular atrial fibrillation? A transthoracic and transesophageal echocardiographic study. Am Heart J 1997;134:745-51.
24. Seward JB, Khandheria BK, Oh JK et al. Transesophageal echocardiography: technique, anatomic correlations, implementation, and clinical applications. Mayo Clin Proc 1988;63:649-80.
25. Santiago D, Warshofsky M, Li Mandri G. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study. J Am Coll Cardiol 1994;24:159-64.
26. Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis. Lancet 2000;355:1936-42.
27. Bertrand ME, Simoons ML, Fox KA et al. for the task force on the management of acute coronary syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23:1809-40.
28. Task Force on Pulmonary Embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000;21:1301-36.
29. Grönefeld GC, Hohnloser SH. Beta-blocker therapy in atrial fibrillation. Pacing Clin Electrophysiol 2003;26:1607-12.
30. Vermes E, Tardif J-C, Bourassa MG et al. Enalapril decreased the incidence of atrial fibrillation inpatients with left ventricular dysfunction. Insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation 2003;107:2926-31.
31. Wachtell K, Lehto M, Gerdts E et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenol. The losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol 2005;45:712-9.